Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 180
8
Diseases
192
Unique genes
0.151
Avg. similarity score
Nephrolithiasis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Nephrolithiasis
Urolithiasis
Hyperuricemia
Bladder calculus
Ureterolithiasis
3-hydroxyisobutyric aciduria
Dalmatian hypouricemia
Osteomalacia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Nephrolithiasis | 5 | 5 | 120 |
| Urolithiasis | 5 | 5 | 69 |
| Hyperuricemia | 4 | 4 | 64 |
| Bladder calculus | 3 | 3 | 40 |
| Ureterolithiasis | 3 | 3 | 10 |
| 3-hydroxyisobutyric aciduria | 2 | 2 | 1 |
| Dalmatian hypouricemia | 1 | 1 | 1 |
| Osteomalacia | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCG2 | 5 / 8 | Bladder calculus, Hyperuricemia, Nephrolithiasis, Ureterolithiasis and 1 more |
| BCAS1 | 5 / 8 | Bladder calculus, Hyperuricemia, Nephrolithiasis, Ureterolithiasis and 1 more |
| ALPL | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| BCAS3 | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| CYP24A1 | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| KLK15 | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| PDILT | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| RGS14 | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| RSPH14 | 4 / 8 | Bladder calculus, Nephrolithiasis, Ureterolithiasis, Urolithiasis |
| VEGFA | 4 / 8 | Bladder calculus, Hyperuricemia, Nephrolithiasis, Urolithiasis |
| ABCC6 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| AP1S3 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| AQP1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| CASR | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| CDK12 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| CLDN14 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| DGKD | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| DGKH | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| GCKR | 3 / 8 | Hyperuricemia, Nephrolithiasis, Urolithiasis |
| GIPC1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| GIPR | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| H1-0 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| HIBADH | 3 / 8 | 3-hydroxyisobutyric aciduria, Nephrolithiasis, Urolithiasis |
| KANSL1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| OVOL1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| PRKAG2 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| PTGER1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| SLC22A2 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| SLC30A10 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| SLC34A1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| STC1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| TFAP2B | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| TFAP2D | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| TNPO1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| TRPV5 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| TRPV6 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| UGT8 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| WDR72 | 3 / 8 | Hyperuricemia, Nephrolithiasis, Urolithiasis |
| ZFPM1 | 3 / 8 | Bladder calculus, Nephrolithiasis, Urolithiasis |
| AHR | 2 / 8 | Bladder calculus, Urolithiasis |
| ARSJ | 2 / 8 | Nephrolithiasis, Urolithiasis |
| CLDN10 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| EPB41L2 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| FTO | 2 / 8 | Nephrolithiasis, Urolithiasis |
| HBB | 2 / 8 | Bladder calculus, Urolithiasis |
| HCRTR2 | 2 / 8 | Hyperuricemia, Urolithiasis |
| KCNK5 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| MAP2K4 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| MEPE | 2 / 8 | Hyperuricemia, Osteomalacia |
| MINDY4 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| MIPOL1 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| NBPF3 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| OPRL1 | 2 / 8 | Bladder calculus, Urolithiasis |
| PKN1 | 2 / 8 | Ureterolithiasis, Urolithiasis |
| SAYSD1 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| SHROOM3 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| SLC17A3 | 2 / 8 | Hyperuricemia, Nephrolithiasis |
| SLC22A12 | 2 / 8 | Dalmatian hypouricemia, Hyperuricemia |
| SLC26A1 | 2 / 8 | Nephrolithiasis, Urolithiasis |
| SNX17 | 2 / 8 | Bladder calculus, Urolithiasis |
| SPATA31H1 | 2 / 8 | Hyperuricemia, Nephrolithiasis |
| TMEM171 | 2 / 8 | Hyperuricemia, Nephrolithiasis |
| UMOD | 2 / 8 | Hyperuricemia, Nephrolithiasis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Parathyroid hormone synthesis, secretion and action | KEGG | 9 / 115 | 4.9× | 9.25e-5 | 2.11e-3 ✓ sig. |
| Type II Na+/Pi cotransporters | Reactome | 2 / 3 | 41.7× | 7.55e-4 | 1.10e-2 ✓ sig. |
| Purine salvage | Reactome | 3 / 13 | 14.4× | 1.02e-3 | 1.38e-2 ✓ sig. |
| Nicotinamide salvaging | Reactome | 3 / 19 | 9.9× | 3.23e-3 | 3.24e-2 ✓ sig. |
| Platelet degranulation | Reactome | 7 / 123 | 3.6× | 3.57e-3 | 3.48e-2 ✓ sig. |
| Cation-coupled Chloride cotransporters | Reactome | 2 / 7 | 17.9× | 5.06e-3 | 4.41e-2 ✓ sig. |
| Virion - Hepatitis viruses | KEGG | 4 / 48 | 5.2× | 7.12e-3 | 5.53e-2 |
| Gamma-carboxylation of protein precursors | Reactome | 2 / 9 | 13.9× | 8.50e-3 | 6.21e-2 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | Reactome | 2 / 9 | 13.9× | 8.50e-3 | 6.21e-2 |
| Erythrocytes take up oxygen and release carbon dioxide | Reactome | 2 / 9 | 13.9× | 8.50e-3 | 6.21e-2 |
| Glyoxylate metabolism and glycine degradation | Reactome | 3 / 28 | 6.7× | 9.82e-3 | 6.79e-2 |
| TRP channels | Reactome | 3 / 28 | 6.7× | 9.82e-3 | 6.79e-2 |
| Glyoxylate and dicarboxylate metabolism | KEGG | 3 / 30 | 6.3× | 1.19e-2 | 7.61e-2 |
| Vitamin D (calciferol) metabolism | Reactome | 2 / 11 | 11.4× | 1.27e-2 | 7.89e-2 |
| Cell adhesion molecules | KEGG | 7 / 160 | 2.7× | 1.44e-2 | 8.50e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| urate metabolic process | GO:0046415 | 5 / 10 | 48.7× | 2.63e-8 | 3.94e-6 ✓ sig. |
| urate transport | GO:0015747 | 5 / 11 | 44.2× | 4.78e-8 | 6.53e-6 ✓ sig. |
| potassium ion homeostasis | GO:0055075 | 6 / 21 | 27.8× | 5.19e-8 | 7.01e-6 ✓ sig. |
| chloride ion homeostasis | GO:0055064 | 5 / 13 | 37.4× | 1.31e-7 | 1.51e-5 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 23 / 667 | 3.4× | 3.91e-7 | 3.80e-5 ✓ sig. |
| renal urate salt excretion | GO:0097744 | 3 / 3 | 97.3× | 1.07e-6 | 8.74e-5 ✓ sig. |
| response to vitamin D | GO:0033280 | 5 / 21 | 23.2× | 1.93e-6 | 1.40e-4 ✓ sig. |
| cellular response to cAMP | GO:0071320 | 7 / 58 | 11.7× | 2.09e-6 | 1.49e-4 ✓ sig. |
| intracellular phosphate ion homeostasis | GO:0030643 | 4 / 10 | 38.9× | 2.16e-6 | 1.53e-4 ✓ sig. |
| kidney development | GO:0001822 | 10 / 146 | 6.7× | 2.74e-6 | 1.85e-4 ✓ sig. |
| renal absorption | GO:0070293 | 4 / 11 | 35.4× | 3.37e-6 | 2.19e-4 ✓ sig. |
| phospholipase C-activating G protein-coupled receptor signaling pathway | GO:0007200 | 9 / 120 | 7.3× | 4.15e-6 | 2.58e-4 ✓ sig. |
| calcium ion homeostasis | GO:0055074 | 6 / 42 | 13.9× | 4.20e-6 | 2.61e-4 ✓ sig. |
| transmembrane transport | GO:0055085 | 19 / 557 | 3.3× | 5.00e-6 | 3.00e-4 ✓ sig. |
| IMP salvage | GO:0032264 | 3 / 5 | 58.4× | 1.05e-5 | 5.42e-4 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bladder calculus | Urolithiasis | 0.571 | 40 | 6.46e-101 | 7.74e-99 ✓ sig. |
| Nephrolithiasis | Urolithiasis | 0.367 | 51 | 1.86e-97 | 2.09e-95 ✓ sig. |
| Bladder calculus | Nephrolithiasis | 0.288 | 36 | 3.36e-74 | 2.66e-72 ✓ sig. |
| Ureterolithiasis | Urolithiasis | 0.143 | 10 | 1.65e-24 | 4.13e-23 ✓ sig. |
| Bladder calculus | Ureterolithiasis | 0.214 | 9 | 2.04e-23 | 4.82e-22 ✓ sig. |
| Nephrolithiasis | Ureterolithiasis | 0.074 | 9 | 7.77e-19 | 1.47e-17 ✓ sig. |
| Hyperuricemia | Nephrolithiasis | 0.051 | 9 | 1.50e-9 | 1.42e-8 ✓ sig. |
| Hyperuricemia | Urolithiasis | 0.047 | 6 | 3.96e-7 | 2.63e-6 ✓ sig. |
| Dalmatian hypouricemia | Hyperuricemia | 0.015 | 1 | 4.16e-3 | 5.23e-3 ✓ sig. |
| Hyperuricemia | Osteomalacia | 0.015 | 1 | 4.16e-3 | 5.23e-3 ✓ sig. |
| 3-hydroxyisobutyric aciduria | Urolithiasis | 0.014 | 1 | 4.48e-3 | 5.60e-3 ✓ sig. |
| 3-hydroxyisobutyric aciduria | Nephrolithiasis | 0.008 | 1 | 7.79e-3 | 9.07e-3 ✓ sig. |